Loading company…
ID 404578051 · FY 2023–2024 · 2 years
Subsidiary of შეზღუდული პასუხისმგებლობის საზოგადოება Quest 100 Biosciences LLC (100.0%)
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| Total Current Assets | 464 | 659 | +41.9% |
| Total Non-Current Assets | 1,005 | 869 | -13.5% |
| TOTAL ASSETS | 1,469 | 1,528 | +4.0% |
| Total Current Liabilities | 25 | 141 | +465.0% |
| Total Non-Current Liabilities | 1,447 | 574 | -60.3% |
| TOTAL LIABILITIES | 1,472 | 716 | -51.4% |
| Total Equity | -2 | 812 | nmf |
| Balance Check (Assets - L&E) | 0 | 0 | |
| Debt analysis | |||
| Total Debt | 25 | 141 | +465.0% |
| Cash & Equivalents | 9 | 61 | +597.7% |
| Net Debt | 16 | 81 | +394.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).